Selected data models

You must log in to select data models for download or further analysis.

7 Search results.
Relevance Rating New first Old first

Response - Baseline Brain Tumor Evaluation Form - 2291059v3.0 - Baseline Brain Tumor Evaluation Form

- 1/9/15 - 1 form, 5 itemgroups, 28 items, 1 language
Itemgroups: CRF Header, Brain: Disease at Baseline, Brain: Measurable Lesion(s) Baseline Evaluation, Brain: Non-measurable/evaluable Lesion(s) Baseline Evaluation, Comments
Baseline Brain Tumor Evaluation Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E12EBFF4-9ABA-55D4-E034-0003BA12F5E7

E3F05 Baseline Primary Brain Tumor Disease Evaluation Form NCT00978458

- 6/16/15 - 1 form, 10 itemgroups, 38 items, 1 language
Itemgroups: Header Module, Data amendment, Section I MEASURABLE LESIONS, T2/FLAIR, T1/Contrast, Section II NON-MEASURABLE LESIONS, T2/FLAIR Non-Measurable Lesions, T1/Contrast Non-Measurable Lesions, Section III, Comments
E3F05 Baseline Primary Brain Tumor Disease Evaluation Form NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6C1947D6-6AFF-2C82-E040-BB89AD4371C6

HIV with Cancer Baseline AMC-061 NCT00890747 - Baseline Evaluation Form HIV with Cancer NCT00890747

- 5/20/15 - 1 form, 4 itemgroups, 19 items, 1 language
Itemgroups: Header Module, SOLID TUMOR/LYMPHOMA ASSESSMENT, KAPOSI'S SARCOMA ASSESSMENT, HEMATOLOGIC MALIGNANCY ASSESSMENT
AMC-061 Baseline Evaluation Form (B61) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy NCT00890747 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=715BD918-9168-2975-E040-BB89AD434610

Brain and Central Nervous System Tumors NCT00887146 Pathology - North Central Cancer Treatment Group N0577 Baseline Blood Specimen Submission Form - 2745906v1.0 - North Central Cancer Treatment Group N0577 Baseline Blood Specimen Submission Form

- 1/8/15 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Header Module, Header
North Central Cancer Treatment Group N0577 Baseline Blood Specimen Submission Form Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C096CEC-6297-47DB-E044-0003BA3F9857

Brain and Central Nervous System Tumors NCT00887146 On-Study - North Central Cancer Treatment Group Baseline CD Submission Form - 2804462v1.0 - North Central Cancer Treatment Group Baseline CD Submission Form

- 1/8/15 - 1 form, 3 itemgroups, 18 items, 1 language
Itemgroups: Header Module, Header, Completed by VIEW Personnel:
North Central Cancer Treatment Group Baseline CD Submission Form Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5C397187-1C79-4DCB-E044-0003BA3F9857

Brain and Central Nervous System Tumors NCT00887146 Treatment - North Central Cancer Treatment Group N0577 Concurrent Treatment Form - Baseline - 2745317v1.0 - North Central Cancer Treatment Group N0577 Concurrent Treatment Form - Baseline

- 1/8/15 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Header, Header
North Central Cancer Treatment Group N0577 Concurrent Treatment Form - Baseline Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C07E8C3-3333-293D-E044-0003BA3F9857

Brain and Central Nervous System Tumors NCT00887146 Treatment - North Central Cancer Treatment Group N0577 Concurrent Steroid and Anticonvulsant Treatment Form - Baseline - 2745270v1.0 - North Central Cancer Treatment Group N0577 Concurrent Steroid and Anticonvulsant Treatment Form - Baseline

- 1/8/15 - 1 form, 3 itemgroups, 28 items, 1 language
Itemgroups: Header, Header, Concomitant Treatmet
North Central Cancer Treatment Group N0577 Concurrent Steroid and Anticonvulsant Treatment Form - Baseline Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C07E8C3-3306-293D-E044-0003BA3F9857

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial